| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Apyrase | 167 | 2025 | 376 | 21.440 |
Why?
|
| Antigens, CD | 156 | 2025 | 4033 | 11.320 |
Why?
|
| Adenosine Triphosphatases | 63 | 2020 | 840 | 5.450 |
Why?
|
| 5'-Nucleotidase | 31 | 2024 | 163 | 5.220 |
Why?
|
| Transplantation, Heterologous | 78 | 2021 | 2391 | 3.990 |
Why?
|
| Adenosine | 44 | 2025 | 812 | 3.650 |
Why?
|
| Adenosine Triphosphate | 62 | 2025 | 2001 | 3.450 |
Why?
|
| Receptors, Purinergic P2 | 25 | 2020 | 151 | 2.530 |
Why?
|
| Receptors, Purinergic | 11 | 2021 | 66 | 2.430 |
Why?
|
| Th17 Cells | 15 | 2024 | 790 | 1.920 |
Why?
|
| Endothelium, Vascular | 47 | 2023 | 4424 | 1.880 |
Why?
|
| Liver Regeneration | 12 | 2020 | 213 | 1.820 |
Why?
|
| Reperfusion Injury | 21 | 2024 | 1043 | 1.770 |
Why?
|
| Platelet Aggregation | 26 | 2021 | 769 | 1.740 |
Why?
|
| Graft Rejection | 51 | 2024 | 4504 | 1.740 |
Why?
|
| Liver | 36 | 2024 | 7571 | 1.600 |
Why?
|
| Platelet Activation | 18 | 2020 | 643 | 1.470 |
Why?
|
| T-Lymphocytes, Regulatory | 25 | 2024 | 3114 | 1.340 |
Why?
|
| Animals | 311 | 2025 | 168939 | 1.340 |
Why?
|
| Crohn Disease | 14 | 2022 | 2286 | 1.330 |
Why?
|
| Swine | 71 | 2023 | 5985 | 1.290 |
Why?
|
| Signal Transduction | 64 | 2024 | 23618 | 1.270 |
Why?
|
| Pyrophosphatases | 9 | 2021 | 142 | 1.260 |
Why?
|
| Receptors, Purinergic P1 | 8 | 2020 | 108 | 1.260 |
Why?
|
| Acute Lung Injury | 5 | 2018 | 377 | 1.210 |
Why?
|
| Adenosine Diphosphate | 21 | 2019 | 421 | 1.170 |
Why?
|
| Mice, Inbred C57BL | 89 | 2025 | 22351 | 1.130 |
Why?
|
| Blood Platelets | 21 | 2020 | 2465 | 1.100 |
Why?
|
| Immune Tolerance | 14 | 2020 | 2328 | 1.080 |
Why?
|
| Hepatitis, Autoimmune | 8 | 2023 | 173 | 1.080 |
Why?
|
| Mice | 159 | 2025 | 81898 | 1.060 |
Why?
|
| Hyperoxia | 4 | 2018 | 259 | 1.050 |
Why?
|
| Inflammation | 32 | 2023 | 10863 | 1.040 |
Why?
|
| Purine Nucleotides | 3 | 2021 | 27 | 1.040 |
Why?
|
| Receptors, Purinergic P2X7 | 11 | 2020 | 86 | 1.030 |
Why?
|
| Papio | 31 | 2014 | 672 | 1.020 |
Why?
|
| Blood Coagulation Disorders | 8 | 2015 | 350 | 1.020 |
Why?
|
| Mice, Knockout | 70 | 2025 | 14473 | 0.990 |
Why?
|
| Cell-Derived Microparticles | 5 | 2020 | 159 | 0.980 |
Why?
|
| Receptors, Aryl Hydrocarbon | 7 | 2023 | 221 | 0.970 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 2 | 2015 | 85 | 0.950 |
Why?
|
| Purines | 5 | 2022 | 615 | 0.940 |
Why?
|
| Inflammatory Bowel Diseases | 8 | 2021 | 2429 | 0.930 |
Why?
|
| Endothelial Cells | 19 | 2024 | 3582 | 0.920 |
Why?
|
| Thrombosis | 23 | 2016 | 2953 | 0.920 |
Why?
|
| CD8-Positive T-Lymphocytes | 10 | 2024 | 4652 | 0.870 |
Why?
|
| Colitis | 8 | 2022 | 1238 | 0.860 |
Why?
|
| Platelet Aggregation Inhibitors | 11 | 2020 | 2763 | 0.840 |
Why?
|
| Graft Survival | 32 | 2015 | 3904 | 0.780 |
Why?
|
| Killer Cells, Natural | 13 | 2022 | 2209 | 0.770 |
Why?
|
| Nucleotides | 8 | 2012 | 454 | 0.760 |
Why?
|
| Hepatectomy | 10 | 2020 | 589 | 0.750 |
Why?
|
| Natural Killer T-Cells | 2 | 2015 | 319 | 0.730 |
Why?
|
| Mucous Membrane | 3 | 2018 | 659 | 0.720 |
Why?
|
| Colon | 10 | 2023 | 1797 | 0.710 |
Why?
|
| Immunity | 3 | 2020 | 1002 | 0.710 |
Why?
|
| Liver Cirrhosis | 8 | 2019 | 1960 | 0.680 |
Why?
|
| Cholangitis, Sclerosing | 2 | 2019 | 179 | 0.680 |
Why?
|
| Heart Transplantation | 25 | 2014 | 3306 | 0.670 |
Why?
|
| Blood Coagulation | 13 | 2019 | 1163 | 0.670 |
Why?
|
| Phosphoric Diester Hydrolases | 4 | 2016 | 205 | 0.660 |
Why?
|
| Animals, Genetically Modified | 20 | 2021 | 1562 | 0.650 |
Why?
|
| Liver Transplantation | 13 | 2021 | 2416 | 0.640 |
Why?
|
| Leukocytes, Mononuclear | 6 | 2022 | 1852 | 0.630 |
Why?
|
| Gene Knockout Techniques | 6 | 2017 | 804 | 0.610 |
Why?
|
| Liver Neoplasms | 14 | 2019 | 4356 | 0.610 |
Why?
|
| Adenosine Deaminase | 5 | 2024 | 253 | 0.600 |
Why?
|
| GPI-Linked Proteins | 9 | 2021 | 472 | 0.600 |
Why?
|
| Carcinoma, Hepatocellular | 9 | 2019 | 2329 | 0.600 |
Why?
|
| Macrophages | 20 | 2020 | 5784 | 0.600 |
Why?
|
| Galactosyltransferases | 13 | 2013 | 283 | 0.590 |
Why?
|
| Protein Engineering | 3 | 2020 | 554 | 0.580 |
Why?
|
| Cell Movement | 13 | 2018 | 5204 | 0.580 |
Why?
|
| Receptor, Adenosine A2A | 7 | 2024 | 128 | 0.580 |
Why?
|
| Blood Vessels | 4 | 2021 | 1111 | 0.560 |
Why?
|
| Melanoma, Experimental | 5 | 2020 | 557 | 0.560 |
Why?
|
| Gene Deletion | 10 | 2021 | 2669 | 0.550 |
Why?
|
| von Willebrand Factor | 9 | 2012 | 680 | 0.550 |
Why?
|
| Myocardial Reperfusion Injury | 8 | 2014 | 483 | 0.540 |
Why?
|
| Anti-Inflammatory Agents | 6 | 2024 | 1805 | 0.530 |
Why?
|
| Receptor, Adenosine A2B | 5 | 2022 | 34 | 0.520 |
Why?
|
| Hemostatic Disorders | 1 | 2015 | 3 | 0.510 |
Why?
|
| Kidney Diseases | 5 | 2020 | 2101 | 0.510 |
Why?
|
| Cell Proliferation | 25 | 2020 | 10451 | 0.510 |
Why?
|
| Sepsis | 7 | 2021 | 2604 | 0.510 |
Why?
|
| CD4-Positive T-Lymphocytes | 9 | 2018 | 4410 | 0.500 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2015 | 96 | 0.500 |
Why?
|
| Cells, Cultured | 46 | 2023 | 18986 | 0.500 |
Why?
|
| Lung | 7 | 2021 | 10068 | 0.500 |
Why?
|
| Kidney | 17 | 2021 | 7073 | 0.490 |
Why?
|
| Kwashiorkor | 1 | 2014 | 24 | 0.490 |
Why?
|
| Oxygen | 5 | 2023 | 4252 | 0.480 |
Why?
|
| Humans | 232 | 2024 | 766812 | 0.480 |
Why?
|
| Liver Neoplasms, Experimental | 2 | 2013 | 189 | 0.470 |
Why?
|
| Diabetic Nephropathies | 3 | 2020 | 975 | 0.470 |
Why?
|
| Bilirubin | 3 | 2022 | 440 | 0.460 |
Why?
|
| Hematopoietic Stem Cells | 6 | 2019 | 3408 | 0.460 |
Why?
|
| Lysophospholipids | 2 | 2015 | 336 | 0.450 |
Why?
|
| Cytokines | 21 | 2024 | 7438 | 0.450 |
Why?
|
| Portal Vein | 3 | 2016 | 437 | 0.450 |
Why?
|
| Colitis, Ulcerative | 7 | 2020 | 1920 | 0.450 |
Why?
|
| Hydrolysis | 10 | 2021 | 645 | 0.440 |
Why?
|
| Disease Models, Animal | 38 | 2024 | 18329 | 0.440 |
Why?
|
| Glycoproteins | 4 | 2016 | 2201 | 0.440 |
Why?
|
| Thromboplastin | 9 | 2017 | 289 | 0.430 |
Why?
|
| Kidney Transplantation | 14 | 2020 | 4278 | 0.430 |
Why?
|
| Calcinosis | 3 | 2023 | 1480 | 0.430 |
Why?
|
| Up-Regulation | 11 | 2020 | 4143 | 0.430 |
Why?
|
| Urinary Bladder | 6 | 2024 | 1155 | 0.420 |
Why?
|
| Forkhead Transcription Factors | 9 | 2024 | 1627 | 0.420 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2021 | 957 | 0.420 |
Why?
|
| Flow Cytometry | 18 | 2024 | 5890 | 0.410 |
Why?
|
| Multienzyme Complexes | 2 | 2015 | 663 | 0.410 |
Why?
|
| Peptides | 10 | 2016 | 4347 | 0.400 |
Why?
|
| Cochlea | 6 | 2010 | 848 | 0.400 |
Why?
|
| Autoimmune Diseases | 6 | 2019 | 2255 | 0.400 |
Why?
|
| T-Lymphocyte Subsets | 6 | 2021 | 1814 | 0.400 |
Why?
|
| Disaccharides | 6 | 2004 | 170 | 0.400 |
Why?
|
| Transplantation Chimera | 5 | 2014 | 609 | 0.390 |
Why?
|
| Transfection | 18 | 2017 | 5755 | 0.390 |
Why?
|
| Blotting, Western | 16 | 2016 | 5022 | 0.380 |
Why?
|
| Atherosclerosis | 3 | 2023 | 3421 | 0.370 |
Why?
|
| Autocrine Communication | 4 | 2021 | 168 | 0.370 |
Why?
|
| Apolipoproteins E | 1 | 2017 | 1459 | 0.370 |
Why?
|
| Hepatocytes | 8 | 2020 | 1246 | 0.370 |
Why?
|
| Antibodies, Heterophile | 6 | 2004 | 128 | 0.360 |
Why?
|
| Dextran Sulfate | 6 | 2022 | 256 | 0.360 |
Why?
|
| Liver Diseases | 3 | 2014 | 1303 | 0.360 |
Why?
|
| Drug Delivery Systems | 2 | 2021 | 2210 | 0.360 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 12 | 2021 | 5753 | 0.360 |
Why?
|
| E-Selectin | 7 | 2002 | 576 | 0.350 |
Why?
|
| Disseminated Intravascular Coagulation | 5 | 2012 | 187 | 0.350 |
Why?
|
| Neutrophils | 9 | 2024 | 3782 | 0.340 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2024 | 1802 | 0.340 |
Why?
|
| Microglia | 5 | 2025 | 1370 | 0.340 |
Why?
|
| Alkaline Phosphatase | 6 | 2024 | 855 | 0.330 |
Why?
|
| Interferon-gamma | 3 | 2022 | 3157 | 0.330 |
Why?
|
| Male | 120 | 2025 | 364154 | 0.330 |
Why?
|
| Sequence Deletion | 3 | 2009 | 1494 | 0.330 |
Why?
|
| Receptors, Purinergic P2Y12 | 3 | 2025 | 117 | 0.330 |
Why?
|
| Intestines | 7 | 2024 | 1904 | 0.330 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2020 | 1144 | 0.320 |
Why?
|
| Rats | 35 | 2024 | 23717 | 0.320 |
Why?
|
| COS Cells | 12 | 2018 | 1135 | 0.320 |
Why?
|
| Bone Marrow Cells | 5 | 2021 | 2413 | 0.320 |
Why?
|
| Apoptosis | 18 | 2024 | 9514 | 0.320 |
Why?
|
| Umbilical Veins | 7 | 2005 | 423 | 0.320 |
Why?
|
| Kupffer Cells | 3 | 2021 | 143 | 0.320 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2018 | 627 | 0.310 |
Why?
|
| Splanchnic Circulation | 1 | 2009 | 122 | 0.310 |
Why?
|
| Concanavalin A | 1 | 2008 | 189 | 0.310 |
Why?
|
| Antibodies, Monoclonal | 9 | 2020 | 9244 | 0.310 |
Why?
|
| Extracellular Space | 2 | 2011 | 563 | 0.310 |
Why?
|
| Gene Expression Regulation, Enzymologic | 6 | 2020 | 1168 | 0.300 |
Why?
|
| Receptors, Purinergic P2X4 | 2 | 2018 | 21 | 0.300 |
Why?
|
| Microcirculation | 8 | 2009 | 1282 | 0.300 |
Why?
|
| Antibodies | 8 | 2014 | 2421 | 0.300 |
Why?
|
| Mitogens | 1 | 2008 | 229 | 0.300 |
Why?
|
| Fatty Liver | 2 | 2022 | 810 | 0.300 |
Why?
|
| Thrombocytopenia | 9 | 2015 | 1172 | 0.300 |
Why?
|
| Immunohistochemistry | 26 | 2018 | 11062 | 0.300 |
Why?
|
| Mitochondria | 7 | 2022 | 3678 | 0.290 |
Why?
|
| Swine, Miniature | 10 | 2012 | 972 | 0.290 |
Why?
|
| Neuroglia | 5 | 2022 | 960 | 0.290 |
Why?
|
| RNA, Messenger | 24 | 2016 | 12795 | 0.280 |
Why?
|
| Interleukin-17 | 6 | 2022 | 923 | 0.280 |
Why?
|
| Acetaminophen | 3 | 2020 | 549 | 0.280 |
Why?
|
| T-Lymphocytes | 10 | 2021 | 10263 | 0.280 |
Why?
|
| Immunologic Memory | 2 | 2021 | 1377 | 0.280 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 15 | 2016 | 4570 | 0.280 |
Why?
|
| Hypertension, Portal | 1 | 2009 | 229 | 0.270 |
Why?
|
| Plasma | 2 | 2020 | 583 | 0.270 |
Why?
|
| Vascular Diseases | 3 | 2022 | 1161 | 0.270 |
Why?
|
| NF-kappa B | 9 | 2017 | 2493 | 0.270 |
Why?
|
| Stem Cell Niche | 3 | 2021 | 346 | 0.270 |
Why?
|
| ran GTP-Binding Protein | 1 | 2006 | 53 | 0.270 |
Why?
|
| Intestinal Mucosa | 6 | 2022 | 3041 | 0.270 |
Why?
|
| Aurintricarboxylic Acid | 3 | 2012 | 10 | 0.260 |
Why?
|
| Necrosis | 5 | 2020 | 1614 | 0.260 |
Why?
|
| Platelet Membrane Glycoproteins | 3 | 2003 | 282 | 0.260 |
Why?
|
| Inflammation Mediators | 4 | 2017 | 1889 | 0.260 |
Why?
|
| Bile Duct Neoplasms | 3 | 2016 | 614 | 0.260 |
Why?
|
| Gastric Bypass | 1 | 2014 | 820 | 0.260 |
Why?
|
| Cell Membrane | 6 | 2018 | 3642 | 0.260 |
Why?
|
| Dendritic Cells | 5 | 2024 | 2747 | 0.260 |
Why?
|
| Pancreas | 3 | 2008 | 1698 | 0.260 |
Why?
|
| Carbon Monoxide | 4 | 2018 | 560 | 0.260 |
Why?
|
| Neoplasms | 9 | 2022 | 22350 | 0.250 |
Why?
|
| Receptors, Purinergic P2Y1 | 5 | 2021 | 40 | 0.250 |
Why?
|
| Serum | 2 | 2017 | 206 | 0.250 |
Why?
|
| Capillary Permeability | 1 | 2009 | 772 | 0.250 |
Why?
|
| Adenine Nucleotides | 3 | 2020 | 111 | 0.250 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2013 | 1121 | 0.250 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2012 | 1105 | 0.240 |
Why?
|
| Fibrosis | 7 | 2023 | 2078 | 0.240 |
Why?
|
| Heart Arrest | 3 | 2024 | 1516 | 0.240 |
Why?
|
| Adenosine Monophosphate | 8 | 2020 | 232 | 0.240 |
Why?
|
| Kynurenine | 3 | 2023 | 142 | 0.240 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2016 | 742 | 0.240 |
Why?
|
| Lipoproteins, VLDL | 2 | 2016 | 198 | 0.240 |
Why?
|
| Rats, Inbred Lew | 11 | 2005 | 1168 | 0.240 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2024 | 1657 | 0.240 |
Why?
|
| Paracrine Communication | 4 | 2021 | 277 | 0.240 |
Why?
|
| Immunosuppressive Agents | 5 | 2015 | 4215 | 0.240 |
Why?
|
| Neovascularization, Pathologic | 2 | 2022 | 2631 | 0.240 |
Why?
|
| Scleroderma, Systemic | 2 | 2022 | 346 | 0.240 |
Why?
|
| Thrombomodulin | 2 | 2011 | 107 | 0.230 |
Why?
|
| Leukocytes | 6 | 2024 | 2034 | 0.230 |
Why?
|
| Complement Activation | 7 | 2005 | 447 | 0.230 |
Why?
|
| STAT3 Transcription Factor | 5 | 2019 | 872 | 0.230 |
Why?
|
| Monocytes | 10 | 2021 | 2599 | 0.230 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2024 | 692 | 0.230 |
Why?
|
| Bone Marrow Transplantation | 6 | 2021 | 2730 | 0.230 |
Why?
|
| Caveolae | 1 | 2004 | 54 | 0.230 |
Why?
|
| Hemolysis | 2 | 2023 | 417 | 0.230 |
Why?
|
| Enteric Nervous System | 2 | 2017 | 213 | 0.230 |
Why?
|
| Pancreatic Diseases | 1 | 2006 | 353 | 0.230 |
Why?
|
| Fibrinolytic Agents | 6 | 2024 | 2078 | 0.230 |
Why?
|
| Hepatitis B virus | 3 | 2019 | 531 | 0.230 |
Why?
|
| Immunity, Innate | 6 | 2022 | 3079 | 0.230 |
Why?
|
| Nucleotidases | 4 | 2012 | 28 | 0.220 |
Why?
|
| Gastrointestinal Agents | 3 | 2021 | 511 | 0.220 |
Why?
|
| Uridine Triphosphate | 4 | 2015 | 29 | 0.220 |
Why?
|
| P-Selectin | 3 | 2020 | 598 | 0.220 |
Why?
|
| Aorta | 10 | 2014 | 2043 | 0.220 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2020 | 1097 | 0.220 |
Why?
|
| Neovascularization, Physiologic | 2 | 2020 | 1368 | 0.220 |
Why?
|
| Pancreatitis | 2 | 2007 | 1087 | 0.220 |
Why?
|
| Prosencephalon | 2 | 2016 | 305 | 0.220 |
Why?
|
| Vitamin D | 4 | 2020 | 3270 | 0.220 |
Why?
|
| Substrate Specificity | 5 | 2020 | 1750 | 0.220 |
Why?
|
| Kinetics | 7 | 2020 | 6288 | 0.210 |
Why?
|
| Vascular Endothelial Growth Factor A | 7 | 2013 | 3511 | 0.210 |
Why?
|
| Immunodominant Epitopes | 1 | 2004 | 244 | 0.210 |
Why?
|
| Transplantation | 1 | 2005 | 222 | 0.210 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2024 | 197 | 0.210 |
Why?
|
| Drug Discovery | 2 | 2020 | 1065 | 0.210 |
Why?
|
| Integrins | 1 | 2007 | 839 | 0.210 |
Why?
|
| Female | 80 | 2025 | 396532 | 0.210 |
Why?
|
| Tumor Necrosis Factor-alpha | 12 | 2022 | 4349 | 0.210 |
Why?
|
| Oxidative Stress | 7 | 2021 | 3139 | 0.210 |
Why?
|
| Blood Proteins | 1 | 2008 | 1194 | 0.210 |
Why?
|
| HEK293 Cells | 4 | 2020 | 4277 | 0.200 |
Why?
|
| Adoptive Transfer | 4 | 2024 | 828 | 0.200 |
Why?
|
| Hepatocyte Growth Factor | 3 | 2020 | 268 | 0.200 |
Why?
|
| Colonic Neoplasms | 3 | 2012 | 2535 | 0.200 |
Why?
|
| Caveolin 1 | 2 | 2020 | 255 | 0.200 |
Why?
|
| Transplantation Conditioning | 8 | 2021 | 1635 | 0.200 |
Why?
|
| MicroRNAs | 5 | 2023 | 3789 | 0.200 |
Why?
|
| Rodentia | 1 | 2024 | 262 | 0.200 |
Why?
|
| Pyruvic Acid | 1 | 2023 | 205 | 0.200 |
Why?
|
| Chagas Disease | 1 | 2024 | 166 | 0.200 |
Why?
|
| Thrombin | 4 | 2003 | 600 | 0.200 |
Why?
|
| Trypanosoma cruzi | 1 | 2024 | 204 | 0.200 |
Why?
|
| Diabetic Angiopathies | 1 | 2007 | 806 | 0.190 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2022 | 637 | 0.190 |
Why?
|
| Myocardium | 10 | 2022 | 4765 | 0.190 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2009 | 1126 | 0.190 |
Why?
|
| Immunomodulation | 3 | 2020 | 548 | 0.190 |
Why?
|
| Adenoviridae | 4 | 2011 | 1093 | 0.190 |
Why?
|
| Mice, Transgenic | 15 | 2019 | 9546 | 0.190 |
Why?
|
| Peritonitis | 1 | 2004 | 368 | 0.190 |
Why?
|
| Recombinant Proteins | 11 | 2024 | 6507 | 0.190 |
Why?
|
| Immunophenotyping | 6 | 2020 | 1867 | 0.190 |
Why?
|
| Polysaccharides, Bacterial | 2 | 2014 | 582 | 0.190 |
Why?
|
| Vasculitis | 2 | 2005 | 528 | 0.180 |
Why?
|
| Heme | 1 | 2023 | 316 | 0.180 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 3 | 2012 | 227 | 0.180 |
Why?
|
| Lymphocytes | 2 | 2020 | 2606 | 0.180 |
Why?
|
| Acute Kidney Injury | 3 | 2021 | 1946 | 0.180 |
Why?
|
| Multiple Organ Failure | 1 | 2023 | 389 | 0.180 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2024 | 484 | 0.180 |
Why?
|
| Aortic Valve Stenosis | 2 | 2023 | 2023 | 0.180 |
Why?
|
| Models, Animal | 5 | 2014 | 2121 | 0.180 |
Why?
|
| Cell Communication | 5 | 2020 | 1660 | 0.180 |
Why?
|
| Health Status | 1 | 2013 | 4087 | 0.180 |
Why?
|
| Structure-Activity Relationship | 3 | 2020 | 3053 | 0.180 |
Why?
|
| Muscle Contraction | 5 | 2019 | 1208 | 0.170 |
Why?
|
| RNA, Antisense | 1 | 2020 | 136 | 0.170 |
Why?
|
| Mice, Inbred Strains | 5 | 2006 | 1767 | 0.170 |
Why?
|
| Benzyl Alcohols | 1 | 2020 | 33 | 0.170 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 5 | 2005 | 144 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 9 | 2021 | 6225 | 0.170 |
Why?
|
| Polymorphism, Genetic | 2 | 2014 | 4249 | 0.170 |
Why?
|
| Immunization | 3 | 2016 | 1218 | 0.170 |
Why?
|
| Interferon-alpha | 1 | 2024 | 910 | 0.170 |
Why?
|
| Oxalates | 1 | 2020 | 99 | 0.170 |
Why?
|
| Liver Function Tests | 4 | 2015 | 527 | 0.170 |
Why?
|
| Basal Metabolism | 1 | 2021 | 163 | 0.170 |
Why?
|
| Myocardial Infarction | 8 | 2022 | 11514 | 0.170 |
Why?
|
| Guinea Pigs | 8 | 2000 | 1309 | 0.170 |
Why?
|
| Anticoagulants | 4 | 2012 | 4854 | 0.170 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2020 | 1664 | 0.170 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 7 | 2017 | 3803 | 0.170 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2022 | 171 | 0.170 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 4 | 2012 | 577 | 0.160 |
Why?
|
| Lymphocyte Activation | 7 | 2018 | 5502 | 0.160 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2020 | 133 | 0.160 |
Why?
|
| Mice, Mutant Strains | 6 | 2020 | 1751 | 0.160 |
Why?
|
| Hepatic Stellate Cells | 1 | 2020 | 117 | 0.160 |
Why?
|
| Protein C | 1 | 2019 | 134 | 0.160 |
Why?
|
| Neuropeptide Y | 1 | 2020 | 194 | 0.160 |
Why?
|
| Inflammasomes | 3 | 2020 | 541 | 0.160 |
Why?
|
| Alanine Transaminase | 4 | 2020 | 608 | 0.160 |
Why?
|
| Gene Expression Regulation | 10 | 2013 | 11924 | 0.160 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2016 | 2426 | 0.160 |
Why?
|
| Insulin Resistance | 2 | 2015 | 3989 | 0.160 |
Why?
|
| Palmitic Acid | 1 | 2000 | 148 | 0.160 |
Why?
|
| Autophagy | 3 | 2020 | 1345 | 0.160 |
Why?
|
| Keratin-18 | 2 | 2016 | 37 | 0.160 |
Why?
|
| Multidrug Resistance-Associated Proteins | 2 | 2018 | 105 | 0.160 |
Why?
|
| Carcinoma 256, Walker | 2 | 2010 | 37 | 0.160 |
Why?
|
| Gene Expression | 12 | 2016 | 7585 | 0.160 |
Why?
|
| Interleukin-8 | 4 | 2016 | 703 | 0.150 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2021 | 195 | 0.150 |
Why?
|
| Astrocytes | 2 | 2006 | 1351 | 0.150 |
Why?
|
| Metalloendopeptidases | 1 | 2000 | 386 | 0.150 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2019 | 141 | 0.150 |
Why?
|
| Epithelial Cells | 3 | 2022 | 3698 | 0.150 |
Why?
|
| Lipoproteins | 2 | 2008 | 871 | 0.150 |
Why?
|
| Graft vs Host Disease | 2 | 2021 | 3079 | 0.150 |
Why?
|
| Blood Transfusion | 2 | 2023 | 1308 | 0.150 |
Why?
|
| Receptors, Purinergic P2Y2 | 4 | 2006 | 18 | 0.150 |
Why?
|
| Ischemic Preconditioning | 2 | 2010 | 89 | 0.150 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2018 | 54 | 0.150 |
Why?
|
| Databases, Nucleic Acid | 1 | 2019 | 203 | 0.150 |
Why?
|
| Feedback, Physiological | 1 | 2020 | 481 | 0.150 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2020 | 350 | 0.150 |
Why?
|
| Glycosylation | 4 | 2017 | 1099 | 0.150 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2020 | 3738 | 0.150 |
Why?
|
| Chemotaxis | 2 | 2013 | 598 | 0.150 |
Why?
|
| Factor Xa | 2 | 2008 | 165 | 0.150 |
Why?
|
| Respiration, Artificial | 2 | 2020 | 2727 | 0.150 |
Why?
|
| Virus Integration | 2 | 2017 | 307 | 0.140 |
Why?
|
| Period Circadian Proteins | 1 | 2018 | 97 | 0.140 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2017 | 72 | 0.140 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2018 | 418 | 0.140 |
Why?
|
| Hemodynamics | 4 | 2023 | 4188 | 0.140 |
Why?
|
| Blood-Brain Barrier | 1 | 2024 | 1028 | 0.140 |
Why?
|
| Pancreatic Neoplasms | 3 | 2023 | 5444 | 0.140 |
Why?
|
| Ultraviolet Rays | 2 | 2021 | 1100 | 0.140 |
Why?
|
| Rats, Wistar | 10 | 2020 | 1887 | 0.140 |
Why?
|
| Sus scrofa | 6 | 2017 | 431 | 0.140 |
Why?
|
| Catalysis | 4 | 2008 | 767 | 0.140 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2020 | 2478 | 0.140 |
Why?
|
| Cell Line, Tumor | 14 | 2021 | 17089 | 0.140 |
Why?
|
| Uridine Diphosphate | 4 | 2013 | 34 | 0.140 |
Why?
|
| Cerebrovascular Circulation | 2 | 2025 | 2671 | 0.140 |
Why?
|
| Fibroblasts | 7 | 2022 | 4166 | 0.140 |
Why?
|
| Time Factors | 20 | 2020 | 40149 | 0.140 |
Why?
|
| Image Cytometry | 1 | 2017 | 51 | 0.140 |
Why?
|
| Cardiotonic Agents | 1 | 2020 | 541 | 0.140 |
Why?
|
| Prothrombin | 1 | 1997 | 194 | 0.140 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2013 | 2882 | 0.140 |
Why?
|
| Tumor Microenvironment | 5 | 2022 | 3942 | 0.140 |
Why?
|
| Immunity, Cellular | 3 | 2020 | 1560 | 0.140 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2022 | 621 | 0.140 |
Why?
|
| Gallbladder Neoplasms | 1 | 2018 | 190 | 0.130 |
Why?
|
| Calcium Signaling | 3 | 2017 | 736 | 0.130 |
Why?
|
| Blood Gas Analysis | 1 | 2017 | 382 | 0.130 |
Why?
|
| Neural Inhibition | 1 | 2020 | 589 | 0.130 |
Why?
|
| Lung Transplantation | 3 | 2013 | 1310 | 0.130 |
Why?
|
| Ischemic Preconditioning, Myocardial | 2 | 2007 | 69 | 0.130 |
Why?
|
| Interleukin-6 | 7 | 2020 | 3226 | 0.130 |
Why?
|
| Nucleoside-Triphosphatase | 4 | 2004 | 19 | 0.130 |
Why?
|
| Ammonia | 1 | 2017 | 245 | 0.130 |
Why?
|
| DNA Primers | 6 | 2012 | 2826 | 0.130 |
Why?
|
| Hepatic Duct, Common | 1 | 2016 | 48 | 0.130 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 2017 | 1494 | 0.130 |
Why?
|
| Plant Lectins | 3 | 2004 | 103 | 0.130 |
Why?
|
| Adult | 35 | 2024 | 223305 | 0.130 |
Why?
|
| I-kappa B Proteins | 1 | 1997 | 210 | 0.130 |
Why?
|
| Interleukin-1 | 1 | 2000 | 1251 | 0.130 |
Why?
|
| Neuromuscular Junction | 2 | 2017 | 399 | 0.130 |
Why?
|
| Receptors, Complement | 3 | 2007 | 254 | 0.130 |
Why?
|
| L-Selectin | 1 | 2016 | 212 | 0.130 |
Why?
|
| Kidney Failure, Chronic | 1 | 2008 | 2505 | 0.130 |
Why?
|
| Receptor, Melatonin, MT1 | 1 | 2016 | 31 | 0.130 |
Why?
|
| Acute Disease | 10 | 2011 | 7240 | 0.130 |
Why?
|
| Bacteroides fragilis | 2 | 2014 | 250 | 0.130 |
Why?
|
| Purinergic Agents | 1 | 2015 | 5 | 0.130 |
Why?
|
| RNA Virus Infections | 1 | 2015 | 18 | 0.130 |
Why?
|
| Intestine, Small | 2 | 2017 | 1217 | 0.130 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2017 | 166 | 0.130 |
Why?
|
| Angiopoietin-1 | 1 | 2016 | 132 | 0.130 |
Why?
|
| Cyclophosphamide | 1 | 2001 | 2234 | 0.130 |
Why?
|
| Sodium Chloride Symporters | 1 | 2015 | 10 | 0.130 |
Why?
|
| Homeostasis | 3 | 2021 | 3343 | 0.130 |
Why?
|
| Gastrointestinal Motility | 1 | 2017 | 235 | 0.120 |
Why?
|
| Bacterial Infections | 1 | 2004 | 1390 | 0.120 |
Why?
|
| Receptor, TIE-2 | 1 | 2016 | 183 | 0.120 |
Why?
|
| Transplantation Immunology | 4 | 2013 | 540 | 0.120 |
Why?
|
| Lysophosphatidylcholines | 1 | 2015 | 77 | 0.120 |
Why?
|
| Base Sequence | 9 | 2011 | 12415 | 0.120 |
Why?
|
| Receptor, Melatonin, MT2 | 1 | 2016 | 83 | 0.120 |
Why?
|
| Eosinophils | 1 | 2020 | 952 | 0.120 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2023 | 996 | 0.120 |
Why?
|
| Natriuresis | 1 | 2015 | 106 | 0.120 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2015 | 51 | 0.120 |
Why?
|
| Endopeptidases | 1 | 1999 | 762 | 0.120 |
Why?
|
| Reactive Oxygen Species | 3 | 2015 | 2144 | 0.120 |
Why?
|
| Placenta | 1 | 2004 | 1726 | 0.120 |
Why?
|
| Immunoconjugates | 2 | 2014 | 976 | 0.120 |
Why?
|
| Angiopoietin-2 | 1 | 2016 | 186 | 0.120 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2016 | 112 | 0.120 |
Why?
|
| Cell Adhesion | 4 | 2020 | 3093 | 0.120 |
Why?
|
| Lectins | 4 | 2013 | 490 | 0.120 |
Why?
|
| Pancreatic Function Tests | 1 | 2014 | 69 | 0.120 |
Why?
|
| Peptide Fragments | 3 | 2020 | 5143 | 0.120 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1791 | 0.120 |
Why?
|
| Erythrocytes | 2 | 2023 | 2412 | 0.120 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2014 | 347 | 0.120 |
Why?
|
| Complement System Proteins | 6 | 2023 | 738 | 0.120 |
Why?
|
| Middle Aged | 30 | 2024 | 223267 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 5 | 2012 | 6066 | 0.120 |
Why?
|
| Encephalomyelitis | 1 | 2014 | 37 | 0.120 |
Why?
|
| Coffee | 1 | 2019 | 594 | 0.110 |
Why?
|
| Heme Oxygenase (Decyclizing) | 3 | 2005 | 165 | 0.110 |
Why?
|
| B-Lymphocytes | 2 | 2015 | 4787 | 0.110 |
Why?
|
| Cell Count | 2 | 2015 | 1826 | 0.110 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2014 | 83 | 0.110 |
Why?
|
| Embolization, Therapeutic | 2 | 2016 | 1403 | 0.110 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 281 | 0.110 |
Why?
|
| Hepatitis B | 2 | 2017 | 710 | 0.110 |
Why?
|
| Malabsorption Syndromes | 1 | 2014 | 135 | 0.110 |
Why?
|
| Coronary Vessels | 3 | 2012 | 3115 | 0.110 |
Why?
|
| Transplantation, Homologous | 7 | 2021 | 4860 | 0.110 |
Why?
|
| Polysaccharides | 1 | 2000 | 1020 | 0.110 |
Why?
|
| Cell Cycle Proteins | 2 | 2016 | 3440 | 0.110 |
Why?
|
| Chromatography, Gel | 1 | 2014 | 634 | 0.110 |
Why?
|
| Bone Marrow | 2 | 2021 | 2926 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2013 | 2060 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2015 | 16044 | 0.110 |
Why?
|
| Taste Buds | 1 | 2013 | 23 | 0.110 |
Why?
|
| Mice, Inbred NOD | 3 | 2023 | 1836 | 0.110 |
Why?
|
| Smoke | 1 | 2015 | 243 | 0.110 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 2 | 2012 | 306 | 0.110 |
Why?
|
| Biological Transport | 2 | 2017 | 2083 | 0.110 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2006 | 2160 | 0.110 |
Why?
|
| Elapid Venoms | 4 | 1996 | 40 | 0.110 |
Why?
|
| Myeloid Cells | 2 | 2020 | 838 | 0.110 |
Why?
|
| Renal Circulation | 3 | 2008 | 288 | 0.110 |
Why?
|
| Molecular Sequence Data | 10 | 2011 | 17609 | 0.110 |
Why?
|
| Acid Anhydride Hydrolases | 3 | 2001 | 67 | 0.110 |
Why?
|
| Receptors, Purinergic P2X1 | 1 | 2013 | 8 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2020 | 2306 | 0.110 |
Why?
|
| Enzyme Inhibitors | 5 | 2018 | 3723 | 0.110 |
Why?
|
| Organogenesis | 1 | 2014 | 214 | 0.110 |
Why?
|
| Immunologic Factors | 3 | 2020 | 1594 | 0.110 |
Why?
|
| Antithrombins | 1 | 1996 | 294 | 0.110 |
Why?
|
| Kidney Neoplasms | 2 | 2020 | 4282 | 0.110 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2013 | 110 | 0.100 |
Why?
|
| Cell Transplantation | 1 | 1995 | 475 | 0.100 |
Why?
|
| Hepatitis | 1 | 2015 | 226 | 0.100 |
Why?
|
| Polymers | 1 | 2020 | 1624 | 0.100 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 857 | 0.100 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2013 | 55 | 0.100 |
Why?
|
| Constriction, Pathologic | 2 | 2023 | 1104 | 0.100 |
Why?
|
| Protein Conformation | 1 | 2020 | 3948 | 0.100 |
Why?
|
| Lipopolysaccharides | 6 | 2020 | 2215 | 0.100 |
Why?
|
| Cell Line | 8 | 2023 | 15564 | 0.100 |
Why?
|
| Noise | 2 | 2006 | 295 | 0.100 |
Why?
|
| Neoplasm Transplantation | 3 | 2019 | 2012 | 0.100 |
Why?
|
| Arteries | 1 | 2017 | 1123 | 0.100 |
Why?
|
| Animals, Laboratory | 1 | 2012 | 46 | 0.100 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2013 | 594 | 0.100 |
Why?
|
| Exosomes | 1 | 2017 | 417 | 0.100 |
Why?
|
| Abortion, Spontaneous | 1 | 2017 | 536 | 0.100 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2012 | 48 | 0.100 |
Why?
|
| Swine Diseases | 1 | 2012 | 61 | 0.100 |
Why?
|
| Somatosensory Disorders | 1 | 2012 | 49 | 0.100 |
Why?
|
| Cholangiocarcinoma | 1 | 2018 | 562 | 0.100 |
Why?
|
| Dermis | 1 | 2013 | 203 | 0.100 |
Why?
|
| Diterpenes | 1 | 2013 | 169 | 0.100 |
Why?
|
| Genetic Engineering | 4 | 2012 | 936 | 0.100 |
Why?
|
| Type C Phospholipases | 1 | 2013 | 287 | 0.100 |
Why?
|
| Membrane Glycoproteins | 2 | 2020 | 3702 | 0.100 |
Why?
|
| Antipyretics | 1 | 2012 | 22 | 0.100 |
Why?
|
| Transgenes | 2 | 2014 | 1014 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2008 | 1677 | 0.100 |
Why?
|
| Aspartate Aminotransferases | 1 | 2014 | 416 | 0.100 |
Why?
|
| Taste | 1 | 2013 | 190 | 0.100 |
Why?
|
| Tyrosine | 2 | 2012 | 1425 | 0.100 |
Why?
|
| Tumor Escape | 2 | 2017 | 371 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2019 | 8623 | 0.100 |
Why?
|
| Macaca fascicularis | 5 | 2014 | 908 | 0.100 |
Why?
|
| Complement Inactivating Agents | 1 | 2012 | 53 | 0.100 |
Why?
|
| Transcription, Genetic | 6 | 2013 | 7612 | 0.100 |
Why?
|
| Adenylate Kinase | 1 | 2012 | 101 | 0.100 |
Why?
|
| Creatinine | 4 | 2013 | 1917 | 0.100 |
Why?
|
| Phosphoproteins | 2 | 2013 | 2448 | 0.100 |
Why?
|
| Connexin 43 | 2 | 2017 | 202 | 0.100 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2014 | 820 | 0.100 |
Why?
|
| L-Lactate Dehydrogenase | 3 | 2003 | 412 | 0.100 |
Why?
|
| DNA Repair | 1 | 2021 | 2050 | 0.100 |
Why?
|
| Hair Cells, Vestibular | 1 | 2012 | 50 | 0.100 |
Why?
|
| Transplantation Tolerance | 4 | 2011 | 641 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 5795 | 0.090 |
Why?
|
| Mutation | 5 | 2022 | 30214 | 0.090 |
Why?
|
| DNA, Viral | 2 | 2017 | 2201 | 0.090 |
Why?
|
| Hep G2 Cells | 3 | 2019 | 378 | 0.090 |
Why?
|
| Interleukins | 1 | 2016 | 796 | 0.090 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 938 | 0.090 |
Why?
|
| Monitoring, Intraoperative | 1 | 2017 | 947 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2015 | 572 | 0.090 |
Why?
|
| Chemokine CXCL12 | 1 | 2013 | 457 | 0.090 |
Why?
|
| Synaptic Transmission | 1 | 2017 | 1175 | 0.090 |
Why?
|
| Cell Hypoxia | 3 | 2018 | 661 | 0.090 |
Why?
|
| Heme Oxygenase-1 | 4 | 2007 | 364 | 0.090 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2011 | 68 | 0.090 |
Why?
|
| Glycolysis | 2 | 2013 | 837 | 0.090 |
Why?
|
| Myocardial Ischemia | 2 | 2020 | 2131 | 0.090 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2017 | 1139 | 0.090 |
Why?
|
| Immunoglobulins | 2 | 2014 | 853 | 0.090 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2010 | 65 | 0.090 |
Why?
|
| Oxygen Consumption | 3 | 2023 | 1874 | 0.090 |
Why?
|
| Ligation | 2 | 2009 | 446 | 0.090 |
Why?
|
| Oxazolone | 1 | 2010 | 61 | 0.090 |
Why?
|
| Genetic Vectors | 1 | 2000 | 3401 | 0.090 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2019 | 1608 | 0.090 |
Why?
|
| Antigens, Neoplasm | 1 | 2019 | 1998 | 0.090 |
Why?
|
| Tungsten Compounds | 1 | 2010 | 10 | 0.090 |
Why?
|
| Hemostasis | 3 | 2013 | 467 | 0.090 |
Why?
|
| Mitosis | 1 | 1996 | 1176 | 0.090 |
Why?
|
| Eye | 1 | 2014 | 711 | 0.090 |
Why?
|
| Postoperative Hemorrhage | 1 | 2014 | 418 | 0.090 |
Why?
|
| Lymphopenia | 1 | 2013 | 300 | 0.090 |
Why?
|
| Neutrophil Infiltration | 1 | 2013 | 392 | 0.090 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2010 | 220 | 0.090 |
Why?
|
| Corneal Transplantation | 1 | 2014 | 315 | 0.090 |
Why?
|
| Phenotype | 6 | 2022 | 16722 | 0.090 |
Why?
|
| RNA | 1 | 2020 | 2715 | 0.090 |
Why?
|
| Proteinuria | 1 | 2013 | 613 | 0.090 |
Why?
|
| Blood Glucose | 3 | 2021 | 6422 | 0.090 |
Why?
|
| Radiation Chimera | 1 | 2010 | 216 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2016 | 18076 | 0.090 |
Why?
|
| Kidney Tubules | 2 | 2012 | 454 | 0.090 |
Why?
|
| Phagocytosis | 2 | 2012 | 1526 | 0.090 |
Why?
|
| Aged | 17 | 2021 | 171344 | 0.090 |
Why?
|
| Aldosterone | 1 | 2015 | 881 | 0.090 |
Why?
|
| Immunoglobulin M | 4 | 2022 | 1527 | 0.090 |
Why?
|
| Neoplasm Metastasis | 3 | 2021 | 4892 | 0.080 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 2 | 2009 | 256 | 0.080 |
Why?
|
| Antithrombin III | 2 | 2002 | 128 | 0.080 |
Why?
|
| Immunoglobulin G | 5 | 2022 | 4559 | 0.080 |
Why?
|
| Toll-Like Receptors | 1 | 2013 | 582 | 0.080 |
Why?
|
| Primates | 5 | 2013 | 519 | 0.080 |
Why?
|
| Antineoplastic Agents | 5 | 2021 | 13644 | 0.080 |
Why?
|
| Neurons | 5 | 2020 | 9515 | 0.080 |
Why?
|
| Amino Acid Sequence | 7 | 2008 | 13411 | 0.080 |
Why?
|
| Cytotoxicity, Immunologic | 3 | 2010 | 1352 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 2 | 2015 | 1492 | 0.080 |
Why?
|
| Cell Death | 2 | 2013 | 1676 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2018 | 1893 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2019 | 9407 | 0.080 |
Why?
|
| Pyridines | 2 | 2019 | 2888 | 0.080 |
Why?
|
| Portal Pressure | 1 | 2009 | 62 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2015 | 12246 | 0.080 |
Why?
|
| Isoenzymes | 4 | 2006 | 1688 | 0.080 |
Why?
|
| Autoimmunity | 2 | 2016 | 1361 | 0.080 |
Why?
|
| Macrophages, Peritoneal | 1 | 2010 | 244 | 0.080 |
Why?
|
| Lung Injury | 2 | 2011 | 432 | 0.080 |
Why?
|
| Adipose Tissue, Brown | 2 | 2021 | 776 | 0.080 |
Why?
|
| Immunotherapy | 2 | 2017 | 4747 | 0.080 |
Why?
|
| Hemorrhage | 4 | 2014 | 3464 | 0.080 |
Why?
|
| Hematologic Diseases | 1 | 2012 | 502 | 0.080 |
Why?
|
| Cloning, Molecular | 3 | 2008 | 4168 | 0.080 |
Why?
|
| Coronary Artery Bypass | 1 | 2017 | 2189 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2020 | 1966 | 0.080 |
Why?
|
| Microchemistry | 1 | 2008 | 54 | 0.080 |
Why?
|
| Neutrophil Activation | 2 | 2006 | 180 | 0.080 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 9528 | 0.080 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2009 | 139 | 0.080 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2013 | 754 | 0.080 |
Why?
|
| Brain | 6 | 2024 | 27158 | 0.080 |
Why?
|
| Ischemia | 3 | 2012 | 1905 | 0.080 |
Why?
|
| Escherichia coli Infections | 1 | 2012 | 518 | 0.080 |
Why?
|
| Cell Differentiation | 7 | 2021 | 11657 | 0.080 |
Why?
|
| Whole-Body Irradiation | 3 | 2012 | 438 | 0.080 |
Why?
|
| Edema | 1 | 2012 | 764 | 0.080 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 2 | 2024 | 151 | 0.080 |
Why?
|
| Metalloproteases | 1 | 2008 | 60 | 0.080 |
Why?
|
| Kidney Glomerulus | 2 | 2008 | 571 | 0.070 |
Why?
|
| Blood | 2 | 2004 | 598 | 0.070 |
Why?
|
| Blood Coagulation Factors | 3 | 2021 | 371 | 0.070 |
Why?
|
| Sp1 Transcription Factor | 1 | 2008 | 143 | 0.070 |
Why?
|
| Cholesterol | 1 | 2017 | 2904 | 0.070 |
Why?
|
| Legionella pneumophila | 1 | 2008 | 50 | 0.070 |
Why?
|
| Enzyme Activation | 4 | 2008 | 3587 | 0.070 |
Why?
|
| Glucose Clamp Technique | 1 | 2008 | 262 | 0.070 |
Why?
|
| Ristocetin | 3 | 2010 | 26 | 0.070 |
Why?
|
| Uridine | 2 | 2023 | 135 | 0.070 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2023 | 757 | 0.070 |
Why?
|
| Calcium | 6 | 2020 | 5783 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2002 | 1131 | 0.070 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 2007 | 0.070 |
Why?
|
| Secretory Vesicles | 1 | 2008 | 127 | 0.070 |
Why?
|
| Pregnancy Proteins | 1 | 2008 | 222 | 0.070 |
Why?
|
| Auditory Threshold | 1 | 2009 | 369 | 0.070 |
Why?
|
| Neural Stem Cells | 1 | 2015 | 895 | 0.070 |
Why?
|
| Thromboembolism | 2 | 2006 | 1003 | 0.070 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 2009 | 144 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2008 | 1244 | 0.070 |
Why?
|
| Mice, Inbred CBA | 2 | 2005 | 439 | 0.070 |
Why?
|
| Glomerular Mesangium | 1 | 2007 | 98 | 0.070 |
Why?
|
| Phosphorylation | 5 | 2013 | 8310 | 0.070 |
Why?
|
| Cholesterol, HDL | 1 | 2014 | 1814 | 0.070 |
Why?
|
| Young Adult | 10 | 2024 | 59939 | 0.070 |
Why?
|
| In Situ Hybridization | 3 | 2008 | 1892 | 0.070 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2007 | 102 | 0.070 |
Why?
|
| Wounds and Injuries | 1 | 2020 | 2513 | 0.070 |
Why?
|
| Gene Transfer Techniques | 3 | 2001 | 1206 | 0.070 |
Why?
|
| DNA Transposable Elements | 1 | 2011 | 764 | 0.070 |
Why?
|
| Interleukin-1beta | 4 | 2017 | 1026 | 0.070 |
Why?
|
| Streptozocin | 1 | 2007 | 189 | 0.070 |
Why?
|
| Models, Biological | 8 | 2019 | 9464 | 0.070 |
Why?
|
| Antigens, Heterophile | 2 | 1998 | 71 | 0.070 |
Why?
|
| Species Specificity | 2 | 2010 | 2413 | 0.070 |
Why?
|
| Epitopes | 5 | 2005 | 2526 | 0.070 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2008 | 415 | 0.070 |
Why?
|
| Tissue Donors | 4 | 2012 | 2392 | 0.070 |
Why?
|
| Postoperative Complications | 5 | 2014 | 15831 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 4 | 2006 | 3759 | 0.070 |
Why?
|
| Protein Binding | 5 | 2018 | 9326 | 0.070 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 440 | 0.070 |
Why?
|
| Neoplasm Proteins | 2 | 2016 | 3600 | 0.070 |
Why?
|
| Interleukin-10 | 3 | 2022 | 1182 | 0.070 |
Why?
|
| Adiponectin | 1 | 2012 | 1121 | 0.070 |
Why?
|
| Repressor Proteins | 2 | 2023 | 2979 | 0.070 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2008 | 558 | 0.070 |
Why?
|
| Sequence Alignment | 3 | 2008 | 2177 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 874 | 0.060 |
Why?
|
| Hippocampus | 2 | 2017 | 3776 | 0.060 |
Why?
|
| Microscopy, Electron | 2 | 2000 | 2551 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2012 | 1362 | 0.060 |
Why?
|
| Oncogene Proteins | 1 | 2010 | 715 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2012 | 12159 | 0.060 |
Why?
|
| Water | 1 | 2012 | 1416 | 0.060 |
Why?
|
| Immunity, Humoral | 1 | 2010 | 609 | 0.060 |
Why?
|
| Plasma Substitutes | 1 | 2005 | 56 | 0.060 |
Why?
|
| Sirolimus | 1 | 2013 | 1540 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 2006 | 1989 | 0.060 |
Why?
|
| Renin | 1 | 2008 | 647 | 0.060 |
Why?
|
| Biliverdine | 1 | 2005 | 28 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 4050 | 0.060 |
Why?
|
| Fibrinolysis | 2 | 2014 | 331 | 0.060 |
Why?
|
| Jurkat Cells | 2 | 2018 | 740 | 0.060 |
Why?
|
| Glioma | 2 | 2011 | 3498 | 0.060 |
Why?
|
| Coronary Thrombosis | 1 | 2008 | 440 | 0.060 |
Why?
|
| Hyperinsulinism | 1 | 2008 | 402 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 3 | 2016 | 1604 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2006 | 463 | 0.060 |
Why?
|
| RNA Probes | 1 | 2005 | 110 | 0.060 |
Why?
|
| Mice, Nude | 4 | 2016 | 3618 | 0.060 |
Why?
|
| Drug Synergism | 4 | 2003 | 1757 | 0.060 |
Why?
|
| Remission Induction | 3 | 2016 | 2413 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2020 | 3186 | 0.060 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2005 | 120 | 0.060 |
Why?
|
| Interleukin-12 | 3 | 2014 | 581 | 0.060 |
Why?
|
| PPAR alpha | 1 | 2006 | 177 | 0.060 |
Why?
|
| Antibody Specificity | 2 | 2005 | 1062 | 0.060 |
Why?
|
| Cell Line, Transformed | 1 | 2006 | 861 | 0.060 |
Why?
|
| Cyclic AMP | 2 | 2011 | 1472 | 0.060 |
Why?
|
| Antibodies, Antinuclear | 1 | 2006 | 340 | 0.060 |
Why?
|
| Chemokines | 2 | 2022 | 963 | 0.060 |
Why?
|
| Muscle, Smooth | 2 | 2019 | 930 | 0.060 |
Why?
|
| Vitamin D Deficiency | 1 | 2014 | 1349 | 0.060 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2005 | 183 | 0.060 |
Why?
|
| Prognosis | 8 | 2018 | 29959 | 0.060 |
Why?
|
| Multipotent Stem Cells | 1 | 2006 | 200 | 0.060 |
Why?
|
| Dipyridamole | 2 | 2003 | 143 | 0.060 |
Why?
|
| Submandibular Gland | 1 | 2004 | 85 | 0.060 |
Why?
|
| Ligands | 2 | 2022 | 3274 | 0.060 |
Why?
|
| Brain Neoplasms | 2 | 2019 | 9101 | 0.060 |
Why?
|
| Seizures | 1 | 2017 | 2996 | 0.060 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 2392 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 2456 | 0.060 |
Why?
|
| Tumor Burden | 1 | 2010 | 1902 | 0.060 |
Why?
|
| Follow-Up Studies | 8 | 2019 | 39312 | 0.060 |
Why?
|
| Vibrissae | 1 | 2025 | 121 | 0.060 |
Why?
|
| Caveolins | 1 | 2004 | 102 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2270 | 0.060 |
Why?
|
| Organ Transplantation | 2 | 2007 | 1172 | 0.060 |
Why?
|
| Dentate Gyrus | 1 | 2005 | 165 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 4903 | 0.060 |
Why?
|
| Glioblastoma | 1 | 2019 | 3458 | 0.060 |
Why?
|
| Pneumonia | 1 | 2015 | 2161 | 0.060 |
Why?
|
| Serum Albumin | 1 | 2007 | 676 | 0.060 |
Why?
|
| Retina | 1 | 2014 | 2660 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2017 | 10745 | 0.050 |
Why?
|
| Hematopoietic System | 1 | 2004 | 110 | 0.050 |
Why?
|
| Splenectomy | 2 | 2002 | 390 | 0.050 |
Why?
|
| Cholinergic Agents | 1 | 2024 | 97 | 0.050 |
Why?
|
| Microscopy, Video | 1 | 2004 | 241 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2017 | 2971 | 0.050 |
Why?
|
| Hemopexin | 1 | 2023 | 33 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2018 | 701 | 0.050 |
Why?
|
| Hydrocarbons | 1 | 2023 | 105 | 0.050 |
Why?
|
| Ion Channels | 1 | 2008 | 1043 | 0.050 |
Why?
|
| Insulin | 3 | 2021 | 6608 | 0.050 |
Why?
|
| Protein Kinases | 2 | 2007 | 1610 | 0.050 |
Why?
|
| Aortic Valve | 2 | 2023 | 1966 | 0.050 |
Why?
|
| Cell Survival | 4 | 2013 | 5749 | 0.050 |
Why?
|
| Rabbits | 3 | 2005 | 4752 | 0.050 |
Why?
|
| Endoscopy | 1 | 2013 | 1854 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2024 | 705 | 0.050 |
Why?
|
| Phosphoglycerate Kinase | 1 | 2022 | 66 | 0.050 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 2022 | 43 | 0.050 |
Why?
|
| Salivary Glands | 1 | 2004 | 231 | 0.050 |
Why?
|
| Oligopeptides | 2 | 1999 | 1195 | 0.050 |
Why?
|
| Peripheral Nervous System | 1 | 2004 | 151 | 0.050 |
Why?
|
| Cyclosporine | 3 | 2012 | 778 | 0.050 |
Why?
|
| Chimera | 1 | 2004 | 454 | 0.050 |
Why?
|
| Ferric Compounds | 2 | 2016 | 376 | 0.050 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 61 | 0.050 |
Why?
|
| CHO Cells | 3 | 2017 | 1376 | 0.050 |
Why?
|
| Protein Interaction Mapping | 1 | 2006 | 621 | 0.050 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 2 | 2000 | 306 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2004 | 939 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 420 | 0.050 |
Why?
|
| Dysarthria | 1 | 2022 | 57 | 0.050 |
Why?
|
| C-Reactive Protein | 4 | 2015 | 3853 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2008 | 980 | 0.050 |
Why?
|
| Benzene | 1 | 2022 | 106 | 0.050 |
Why?
|
| Chemokine CCL2 | 2 | 2001 | 605 | 0.050 |
Why?
|
| Doxorubicin | 2 | 2023 | 2229 | 0.050 |
Why?
|
| Cytoskeleton | 2 | 2005 | 1179 | 0.050 |
Why?
|
| Permeability | 1 | 2004 | 721 | 0.050 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2005 | 373 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 5888 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2010 | 2887 | 0.050 |
Why?
|
| DNA-Binding Proteins | 3 | 2013 | 9613 | 0.050 |
Why?
|
| Paraplegia | 1 | 2022 | 161 | 0.050 |
Why?
|
| Genotype | 2 | 2009 | 13036 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 5860 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2010 | 1600 | 0.050 |
Why?
|
| Chlorides | 2 | 2016 | 666 | 0.050 |
Why?
|
| Langerhans Cells | 1 | 2002 | 169 | 0.050 |
Why?
|
| Cricetinae | 5 | 2005 | 2416 | 0.050 |
Why?
|
| Integrin beta3 | 1 | 2001 | 120 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2021 | 65286 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2015 | 3796 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 5753 | 0.050 |
Why?
|
| Disulfides | 1 | 2003 | 462 | 0.050 |
Why?
|
| Acetylcysteine | 1 | 2022 | 262 | 0.050 |
Why?
|
| Dipeptides | 1 | 2003 | 386 | 0.050 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2001 | 183 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2013 | 4926 | 0.050 |
Why?
|
| Receptor, Adenosine A1 | 1 | 2020 | 42 | 0.050 |
Why?
|
| Thromboxane A2 | 1 | 2000 | 87 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 2 | 2018 | 1612 | 0.040 |
Why?
|
| Receptors, Growth Factor | 1 | 2001 | 324 | 0.040 |
Why?
|
| Prospective Studies | 8 | 2017 | 54872 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 3 | 2020 | 6105 | 0.040 |
Why?
|
| Weibel-Palade Bodies | 1 | 2000 | 19 | 0.040 |
Why?
|
| Peroxidase | 1 | 2004 | 610 | 0.040 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2020 | 37 | 0.040 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 3246 | 0.040 |
Why?
|
| Neutralization Tests | 1 | 2022 | 736 | 0.040 |
Why?
|
| Capillaries | 1 | 2004 | 755 | 0.040 |
Why?
|
| Myeloablative Agonists | 1 | 2021 | 215 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2021 | 254 | 0.040 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2021 | 324 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 2003 | 575 | 0.040 |
Why?
|
| Endothelium | 2 | 2002 | 768 | 0.040 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 2000 | 58 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 4 | 2014 | 5795 | 0.040 |
Why?
|
| Bile Canaliculi | 1 | 2000 | 12 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2006 | 1326 | 0.040 |
Why?
|
| Cerebral Ventricles | 1 | 2003 | 550 | 0.040 |
Why?
|
| Culture Media, Serum-Free | 1 | 2000 | 147 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 3605 | 0.040 |
Why?
|
| Guanosine Diphosphate | 2 | 2012 | 79 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2009 | 2140 | 0.040 |
Why?
|
| RNA, Small Interfering | 3 | 2018 | 3427 | 0.040 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2011 | 1642 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2006 | 1729 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 1646 | 0.040 |
Why?
|
| Cathelicidins | 1 | 2020 | 81 | 0.040 |
Why?
|
| Chromatography, Thin Layer | 1 | 2000 | 211 | 0.040 |
Why?
|
| Cognition | 1 | 2017 | 7057 | 0.040 |
Why?
|
| Tissue Distribution | 3 | 2002 | 2275 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2008 | 1466 | 0.040 |
Why?
|
| Stem Cell Factor | 1 | 2000 | 194 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2006 | 1350 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2011 | 1965 | 0.040 |
Why?
|
| Catheter Ablation | 1 | 2013 | 2787 | 0.040 |
Why?
|
| Suramin | 2 | 2015 | 34 | 0.040 |
Why?
|
| Perfusion | 2 | 2013 | 1409 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2008 | 1806 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2005 | 1103 | 0.040 |
Why?
|
| Plant Extracts | 1 | 2003 | 496 | 0.040 |
Why?
|
| Epoprostenol | 1 | 2000 | 246 | 0.040 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2001 | 132 | 0.040 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1999 | 187 | 0.040 |
Why?
|
| Glycine | 1 | 2003 | 670 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 1999 | 201 | 0.040 |
Why?
|
| Vasodilation | 1 | 2023 | 968 | 0.040 |
Why?
|
| Erythrocyte Membrane | 1 | 2001 | 438 | 0.040 |
Why?
|
| Microscopy, Confocal | 3 | 2012 | 1969 | 0.040 |
Why?
|
| Purinergic P1 Receptor Agonists | 1 | 2018 | 39 | 0.040 |
Why?
|
| Interleukin-3 | 1 | 2000 | 425 | 0.040 |
Why?
|
| Cyclooxygenase 2 | 1 | 2021 | 597 | 0.040 |
Why?
|
| CD40 Ligand | 1 | 2001 | 528 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2004 | 1838 | 0.040 |
Why?
|
| Cyclins | 2 | 2012 | 605 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 2000 | 521 | 0.040 |
Why?
|
| Homeodomain Proteins | 2 | 2022 | 2429 | 0.040 |
Why?
|
| Membrane Microdomains | 1 | 2020 | 205 | 0.040 |
Why?
|
| Transcription Factor RelB | 1 | 1998 | 29 | 0.040 |
Why?
|
| GTP Cyclohydrolase | 1 | 2018 | 46 | 0.040 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2000 | 361 | 0.040 |
Why?
|
| ADAM Proteins | 1 | 2000 | 243 | 0.040 |
Why?
|
| Smoking | 1 | 2015 | 9077 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2003 | 754 | 0.040 |
Why?
|
| Methyltransferases | 1 | 2021 | 373 | 0.040 |
Why?
|
| Urinary Bladder Diseases | 1 | 2019 | 166 | 0.040 |
Why?
|
| Phospholipids | 1 | 2022 | 778 | 0.040 |
Why?
|
| Endotoxemia | 1 | 2000 | 198 | 0.040 |
Why?
|
| Germ Cells | 1 | 2022 | 644 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2001 | 806 | 0.040 |
Why?
|
| Feces | 2 | 2016 | 1505 | 0.040 |
Why?
|
| Obesity | 1 | 2021 | 13090 | 0.040 |
Why?
|
| Binding Sites | 3 | 2012 | 6013 | 0.040 |
Why?
|
| Coenzymes | 1 | 2018 | 101 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2019 | 1968 | 0.040 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2001 | 661 | 0.040 |
Why?
|
| Proteins | 3 | 2013 | 6002 | 0.040 |
Why?
|
| Benzylamines | 2 | 1996 | 251 | 0.040 |
Why?
|
| Erythrocyte Transfusion | 1 | 2023 | 574 | 0.040 |
Why?
|
| Heart Failure | 1 | 2022 | 11879 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 2 | 2022 | 2011 | 0.040 |
Why?
|
| Receptors, Cell Surface | 2 | 2005 | 2815 | 0.040 |
Why?
|
| Complement C3d | 1 | 2017 | 21 | 0.040 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2018 | 164 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2023 | 8108 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2011 | 2470 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2020 | 616 | 0.040 |
Why?
|
| Adipose Tissue, White | 1 | 2021 | 371 | 0.040 |
Why?
|
| ROC Curve | 2 | 2016 | 3621 | 0.040 |
Why?
|
| Partial Pressure | 1 | 2017 | 247 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2022 | 734 | 0.040 |
Why?
|
| Bacteria | 1 | 2008 | 2212 | 0.040 |
Why?
|
| STAT1 Transcription Factor | 1 | 2019 | 340 | 0.040 |
Why?
|
| Cytoplasmic Granules | 1 | 2020 | 574 | 0.040 |
Why?
|
| Hypertension | 1 | 2017 | 8616 | 0.040 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2000 | 633 | 0.040 |
Why?
|
| Hemostatics | 1 | 2000 | 247 | 0.040 |
Why?
|
| Purinergic P2X Receptor Antagonists | 1 | 2017 | 24 | 0.040 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2017 | 76 | 0.040 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2001 | 566 | 0.040 |
Why?
|
| Chromosome Fragile Sites | 1 | 2017 | 26 | 0.040 |
Why?
|
| Adenosine A2 Receptor Agonists | 1 | 2017 | 31 | 0.040 |
Why?
|
| Angioplasty, Balloon | 1 | 2001 | 592 | 0.040 |
Why?
|
| Lymphokines | 1 | 2020 | 924 | 0.040 |
Why?
|
| Muscle Relaxation | 1 | 2017 | 138 | 0.040 |
Why?
|
| Superoxides | 1 | 1998 | 388 | 0.030 |
Why?
|
| Muscle, Skeletal | 2 | 2012 | 4968 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2020 | 1647 | 0.030 |
Why?
|
| Femoral Artery | 1 | 2001 | 827 | 0.030 |
Why?
|
| Antigen Presentation | 2 | 2013 | 1250 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2008 | 2903 | 0.030 |
Why?
|
| Serotonin | 1 | 2001 | 1045 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2015 | 9358 | 0.030 |
Why?
|
| Injections, Intra-Arterial | 1 | 1996 | 181 | 0.030 |
Why?
|
| Renin-Angiotensin System | 1 | 2021 | 736 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1999 | 462 | 0.030 |
Why?
|
| Kidney Function Tests | 2 | 2010 | 685 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2017 | 275 | 0.030 |
Why?
|
| Cytomegalovirus Infections | 1 | 2003 | 838 | 0.030 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 1998 | 426 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2006 | 2841 | 0.030 |
Why?
|
| alpha-Defensins | 1 | 2016 | 30 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1999 | 2168 | 0.030 |
Why?
|
| Mucin-2 | 1 | 2016 | 50 | 0.030 |
Why?
|
| Sensitivity and Specificity | 4 | 2017 | 14653 | 0.030 |
Why?
|
| Ritonavir | 1 | 2018 | 331 | 0.030 |
Why?
|
| Factor VIIa | 1 | 1997 | 103 | 0.030 |
Why?
|
| Membrane Potentials | 2 | 2011 | 1085 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 2 | 2016 | 1996 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1996 | 363 | 0.030 |
Why?
|
| Catalase | 1 | 2016 | 215 | 0.030 |
Why?
|
| Antibody Affinity | 1 | 2017 | 251 | 0.030 |
Why?
|
| Antigens | 1 | 2001 | 1442 | 0.030 |
Why?
|
| Hybridomas | 1 | 2017 | 442 | 0.030 |
Why?
|
| Spumavirus | 1 | 2015 | 17 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2012 | 11218 | 0.030 |
Why?
|
| Calgranulin B | 1 | 2016 | 87 | 0.030 |
Why?
|
| Glucose | 1 | 2008 | 4340 | 0.030 |
Why?
|
| Chemokine CXCL2 | 1 | 2015 | 105 | 0.030 |
Why?
|
| Retroviridae | 1 | 1998 | 846 | 0.030 |
Why?
|
| Disease Progression | 3 | 2019 | 13642 | 0.030 |
Why?
|
| Adolescent | 7 | 2024 | 88902 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2000 | 1228 | 0.030 |
Why?
|
| Cattle | 2 | 1998 | 3815 | 0.030 |
Why?
|
| Arenaviridae Infections | 1 | 2015 | 53 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2006 | 2902 | 0.030 |
Why?
|
| Receptors, Adenosine A2 | 1 | 2015 | 14 | 0.030 |
Why?
|
| Alcoholism | 1 | 2006 | 1980 | 0.030 |
Why?
|
| Cell Membrane Permeability | 2 | 2010 | 568 | 0.030 |
Why?
|
| Antibodies, Blocking | 1 | 1996 | 250 | 0.030 |
Why?
|
| Factor VII | 1 | 2015 | 139 | 0.030 |
Why?
|
| Animals, Newborn | 3 | 2008 | 2677 | 0.030 |
Why?
|
| Immunization, Passive | 1 | 2017 | 618 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1997 | 1550 | 0.030 |
Why?
|
| Cricetulus | 1 | 2017 | 810 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2000 | 1505 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 13489 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2016 | 2931 | 0.030 |
Why?
|
| Fibrinogen | 1 | 1998 | 893 | 0.030 |
Why?
|
| Coronary Circulation | 2 | 2014 | 1602 | 0.030 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2015 | 140 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 2020 | 1516 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2022 | 1281 | 0.030 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2015 | 176 | 0.030 |
Why?
|
| Triglycerides | 1 | 2022 | 2441 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 1997 | 610 | 0.030 |
Why?
|
| Morganella morganii | 1 | 2014 | 9 | 0.030 |
Why?
|
| Streptomycin | 1 | 2014 | 69 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2016 | 685 | 0.030 |
Why?
|
| Deoxyribonucleotides | 1 | 2014 | 43 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 12985 | 0.030 |
Why?
|
| Pedigree | 1 | 2022 | 4539 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 1998 | 1525 | 0.030 |
Why?
|
| Donor Selection | 1 | 2016 | 242 | 0.030 |
Why?
|
| Aging | 1 | 2013 | 8728 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 2020 | 1218 | 0.030 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2015 | 238 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2001 | 1621 | 0.030 |
Why?
|
| Collagen | 1 | 2022 | 2635 | 0.030 |
Why?
|
| Ampicillin | 1 | 2014 | 138 | 0.030 |
Why?
|
| Chorda Tympani Nerve | 1 | 2013 | 11 | 0.030 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2013 | 46 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2015 | 915 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2016 | 596 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2021 | 1756 | 0.030 |
Why?
|
| Glossopharyngeal Nerve | 1 | 2013 | 18 | 0.030 |
Why?
|
| Cold Ischemia | 1 | 2014 | 72 | 0.030 |
Why?
|
| Enzyme Induction | 2 | 2007 | 455 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 2 | 2015 | 3610 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 1998 | 1617 | 0.030 |
Why?
|
| Starvation | 1 | 2014 | 141 | 0.030 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 899 | 0.030 |
Why?
|
| Epidermis | 1 | 2016 | 539 | 0.030 |
Why?
|
| Estrenes | 1 | 2013 | 21 | 0.030 |
Why?
|
| Risk Factors | 6 | 2021 | 74889 | 0.030 |
Why?
|
| Fucosyltransferases | 1 | 2013 | 118 | 0.030 |
Why?
|
| Heparin | 1 | 2000 | 1636 | 0.030 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2015 | 291 | 0.030 |
Why?
|
| Receptors, GABA-A | 1 | 2017 | 624 | 0.030 |
Why?
|
| Platelet Count | 2 | 2006 | 784 | 0.030 |
Why?
|
| Aspirin | 1 | 2005 | 3134 | 0.030 |
Why?
|
| Action Potentials | 1 | 2020 | 1835 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2008 | 5330 | 0.030 |
Why?
|
| Gene Regulatory Networks | 2 | 2013 | 1752 | 0.030 |
Why?
|
| Inosine | 1 | 2013 | 129 | 0.030 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily C | 1 | 2012 | 38 | 0.030 |
Why?
|
| Water Deprivation | 1 | 2012 | 19 | 0.030 |
Why?
|
| Kidney Concentrating Ability | 1 | 2012 | 34 | 0.030 |
Why?
|
| Papio hamadryas | 1 | 2012 | 32 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2001 | 1895 | 0.030 |
Why?
|
| Bleomycin | 1 | 2013 | 492 | 0.030 |
Why?
|
| Renal Agents | 1 | 2012 | 30 | 0.030 |
Why?
|
| Enterococcus faecalis | 1 | 2014 | 244 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 367 | 0.030 |
Why?
|
| Receptors, Cytokine | 1 | 2013 | 258 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 1080 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2013 | 6214 | 0.030 |
Why?
|
| alpha-Fetoproteins | 1 | 2013 | 229 | 0.030 |
Why?
|
| Pyrrolidinones | 1 | 2013 | 116 | 0.030 |
Why?
|
| Receptors, Purinergic P2Y | 1 | 2012 | 23 | 0.030 |
Why?
|
| Phenylalanine | 1 | 2014 | 367 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 2006 | 2596 | 0.030 |
Why?
|
| Leukapheresis | 1 | 2012 | 150 | 0.030 |
Why?
|
| Suppressor Factors, Immunologic | 1 | 2012 | 68 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2015 | 479 | 0.020 |
Why?
|
| Receptors, Interleukin | 1 | 2013 | 243 | 0.020 |
Why?
|
| Immunotoxins | 1 | 2012 | 175 | 0.020 |
Why?
|
| Complement Pathway, Classical | 1 | 2012 | 91 | 0.020 |
Why?
|
| Ventricular Function, Left | 2 | 2020 | 3934 | 0.020 |
Why?
|
| Stem Cells | 1 | 2005 | 3536 | 0.020 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2012 | 87 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 1130 | 0.020 |
Why?
|
| Hydrolases | 1 | 2013 | 146 | 0.020 |
Why?
|
| Particle Size | 1 | 2016 | 1633 | 0.020 |
Why?
|
| Escherichia coli | 2 | 2014 | 4211 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2012 | 203 | 0.020 |
Why?
|
| Troponin I | 2 | 2007 | 659 | 0.020 |
Why?
|
| Hematocrit | 2 | 2003 | 622 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2017 | 1438 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2015 | 1529 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 800 | 0.020 |
Why?
|
| Macrophage-1 Antigen | 1 | 2012 | 286 | 0.020 |
Why?
|
| Symbiosis | 1 | 2014 | 297 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 1331 | 0.020 |
Why?
|
| Survival Rate | 2 | 2016 | 12826 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2012 | 381 | 0.020 |
Why?
|
| Mucin-1 | 1 | 2016 | 536 | 0.020 |
Why?
|
| Uridine Monophosphate | 1 | 2012 | 67 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2000 | 2875 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2012 | 199 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 2001 | 1285 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2015 | 1639 | 0.020 |
Why?
|
| Blood Pressure | 3 | 2015 | 8533 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2016 | 10101 | 0.020 |
Why?
|
| Informed Consent | 1 | 1998 | 1010 | 0.020 |
Why?
|
| Mesocricetus | 2 | 2002 | 256 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2012 | 655 | 0.020 |
Why?
|
| DNA Damage | 1 | 2021 | 2469 | 0.020 |
Why?
|
| Health Education | 1 | 1998 | 1060 | 0.020 |
Why?
|
| Drug Interactions | 2 | 2008 | 1419 | 0.020 |
Why?
|
| Drinking | 1 | 2012 | 196 | 0.020 |
Why?
|
| Vascular Patency | 1 | 2014 | 915 | 0.020 |
Why?
|
| Pregnancy | 4 | 2019 | 30236 | 0.020 |
Why?
|
| Receptors, Chemokine | 1 | 2014 | 652 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 616 | 0.020 |
Why?
|
| Myocardial Reperfusion | 1 | 2012 | 338 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 1996 | 2221 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2018 | 4019 | 0.020 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 59548 | 0.020 |
Why?
|
| Infection Control | 1 | 1998 | 984 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2012 | 789 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 3828 | 0.020 |
Why?
|
| Insulinoma | 1 | 2011 | 121 | 0.020 |
Why?
|
| Antioxidants | 1 | 1998 | 1671 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2017 | 26309 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2013 | 939 | 0.020 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2011 | 125 | 0.020 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2011 | 170 | 0.020 |
Why?
|
| Exoribonucleases | 1 | 2010 | 88 | 0.020 |
Why?
|
| Etoposide | 1 | 2011 | 638 | 0.020 |
Why?
|
| Thiophenes | 1 | 2014 | 570 | 0.020 |
Why?
|
| Iron | 1 | 2018 | 1812 | 0.020 |
Why?
|
| Granulocytes | 1 | 2012 | 551 | 0.020 |
Why?
|
| Organ of Corti | 1 | 2010 | 85 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 678 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2010 | 130 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2010 | 185 | 0.020 |
Why?
|
| Smad Proteins | 1 | 2010 | 157 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2012 | 328 | 0.020 |
Why?
|
| Ticlopidine | 1 | 2014 | 729 | 0.020 |
Why?
|
| Sodium | 1 | 2015 | 1594 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2013 | 792 | 0.020 |
Why?
|
| Ribonucleases | 1 | 2010 | 266 | 0.020 |
Why?
|
| Tetrazolium Salts | 1 | 2009 | 92 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 2013 | 650 | 0.020 |
Why?
|
| Nucleosides | 1 | 2010 | 130 | 0.020 |
Why?
|
| Quinacrine | 2 | 1999 | 24 | 0.020 |
Why?
|
| Dogs | 1 | 2014 | 3834 | 0.020 |
Why?
|
| Cations | 1 | 2010 | 239 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 3 | 2012 | 7475 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2535 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2014 | 1736 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 2018 | 1168 | 0.020 |
Why?
|
| Ventricular Fibrillation | 1 | 2012 | 538 | 0.020 |
Why?
|
| Cell Division | 2 | 2008 | 4473 | 0.020 |
Why?
|
| Reference Values | 1 | 2016 | 4914 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2013 | 562 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 1996 | 1895 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2010 | 751 | 0.020 |
Why?
|
| Spiral Ganglion | 1 | 2010 | 180 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2017 | 4618 | 0.020 |
Why?
|
| Skin Transplantation | 1 | 2014 | 1097 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2014 | 1164 | 0.020 |
Why?
|
| Receptors, CXCR4 | 1 | 2013 | 729 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2012 | 1606 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2015 | 863 | 0.020 |
Why?
|
| Heart Rate | 2 | 2012 | 4207 | 0.020 |
Why?
|
| Cytidine | 1 | 2008 | 60 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2016 | 1409 | 0.020 |
Why?
|
| Ascites | 1 | 2010 | 336 | 0.020 |
Why?
|
| Spleen | 1 | 2014 | 2295 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 1697 | 0.020 |
Why?
|
| NAD | 1 | 2012 | 617 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2008 | 364 | 0.020 |
Why?
|
| Killer Cells, Lymphokine-Activated | 1 | 2007 | 42 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2017 | 22248 | 0.020 |
Why?
|
| Facial Nerve Diseases | 1 | 2008 | 49 | 0.020 |
Why?
|
| Ureter | 2 | 2001 | 364 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6514 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 610 | 0.020 |
Why?
|
| Adenosine-5'-(N-ethylcarboxamide) | 1 | 2007 | 16 | 0.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2011 | 617 | 0.020 |
Why?
|
| Membrane Proteins | 3 | 2005 | 7869 | 0.020 |
Why?
|
| Antibody Formation | 2 | 2002 | 1392 | 0.020 |
Why?
|
| Hepatitis C, Chronic | 1 | 2015 | 1033 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2012 | 2626 | 0.020 |
Why?
|
| Hair Cells, Auditory | 1 | 2010 | 382 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 2013 | 744 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2007 | 6965 | 0.020 |
Why?
|
| Caspases | 1 | 2010 | 881 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2007 | 187 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2010 | 661 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2009 | 565 | 0.020 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2014 | 1065 | 0.020 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2006 | 221 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2009 | 839 | 0.020 |
Why?
|
| Cerebral Arteries | 1 | 2008 | 490 | 0.020 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2006 | 133 | 0.020 |
Why?
|
| Entorhinal Cortex | 1 | 2008 | 285 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 20146 | 0.020 |
Why?
|
| Tetrazoles | 1 | 2012 | 923 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1998 | 4523 | 0.020 |
Why?
|
| Fetus | 2 | 2004 | 1878 | 0.020 |
Why?
|
| Motor Activity | 1 | 2016 | 2711 | 0.020 |
Why?
|
| Purinergic P2 Receptor Antagonists | 1 | 2006 | 67 | 0.020 |
Why?
|
| Linear Models | 1 | 2016 | 5873 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2015 | 2060 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 2721 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2006 | 294 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 2783 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 2744 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2016 | 24299 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2008 | 924 | 0.020 |
Why?
|
| Renal Artery | 1 | 2007 | 355 | 0.020 |
Why?
|
| Eating | 1 | 2012 | 1539 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 2045 | 0.020 |
Why?
|
| Organ Size | 1 | 2010 | 2262 | 0.020 |
Why?
|
| Dependovirus | 1 | 2010 | 720 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8540 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2016 | 3468 | 0.010 |
Why?
|
| Mixed Function Oxygenases | 1 | 2006 | 265 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 2005 | 167 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2008 | 1159 | 0.010 |
Why?
|
| Child | 4 | 2016 | 80670 | 0.010 |
Why?
|
| Boston | 1 | 2017 | 9346 | 0.010 |
Why?
|
| Protoporphyrins | 1 | 2005 | 167 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2013 | 2115 | 0.010 |
Why?
|
| Public Health | 1 | 1998 | 2680 | 0.010 |
Why?
|
| Consensus | 1 | 2014 | 3208 | 0.010 |
Why?
|
| United States | 4 | 2016 | 72945 | 0.010 |
Why?
|
| Satellite Cells, Perineuronal | 1 | 2004 | 4 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 2017 | 8045 | 0.010 |
Why?
|
| Ganglia | 1 | 2004 | 86 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2006 | 1377 | 0.010 |
Why?
|
| Alleles | 1 | 2015 | 6896 | 0.010 |
Why?
|
| Piperazines | 1 | 2014 | 2547 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2006 | 590 | 0.010 |
Why?
|
| Sulfoxides | 1 | 2003 | 47 | 0.010 |
Why?
|
| Recurrence | 1 | 2016 | 8507 | 0.010 |
Why?
|
| Garlic | 1 | 2003 | 28 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2017 | 12430 | 0.010 |
Why?
|
| Metals | 1 | 2008 | 711 | 0.010 |
Why?
|
| Crotalid Venoms | 1 | 2003 | 29 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 2005 | 684 | 0.010 |
Why?
|
| Blood Physiological Phenomena | 1 | 2003 | 53 | 0.010 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 2003 | 38 | 0.010 |
Why?
|
| Thromboxane B2 | 1 | 2003 | 143 | 0.010 |
Why?
|
| Tenascin | 1 | 2003 | 61 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2006 | 697 | 0.010 |
Why?
|
| Schwann Cells | 1 | 2004 | 195 | 0.010 |
Why?
|
| Corticosterone | 1 | 2004 | 301 | 0.010 |
Why?
|
| Hemagglutinins | 1 | 2003 | 111 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2019 | 81657 | 0.010 |
Why?
|
| Heart | 1 | 1996 | 4425 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 2003 | 416 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2012 | 2253 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12064 | 0.010 |
Why?
|
| Irritants | 1 | 2002 | 42 | 0.010 |
Why?
|
| Vimentin | 1 | 2003 | 257 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2015 | 5990 | 0.010 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2002 | 158 | 0.010 |
Why?
|
| Liposomes | 1 | 2006 | 787 | 0.010 |
Why?
|
| Leukocyte Transfusion | 1 | 2001 | 58 | 0.010 |
Why?
|
| Research Design | 1 | 2017 | 6206 | 0.010 |
Why?
|
| Thiazoles | 1 | 2009 | 1529 | 0.010 |
Why?
|
| Purinergic P2 Receptor Agonists | 1 | 2001 | 13 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 7841 | 0.010 |
Why?
|
| Introns | 1 | 2004 | 966 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2002 | 573 | 0.010 |
Why?
|
| Histamine | 1 | 2003 | 496 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 2629 | 0.010 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2002 | 303 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2014 | 3429 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2009 | 1927 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2003 | 564 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 1615 | 0.010 |
Why?
|
| History, 17th Century | 1 | 2001 | 108 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 12536 | 0.010 |
Why?
|
| Random Allocation | 1 | 2005 | 2394 | 0.010 |
Why?
|
| Cytosol | 1 | 2004 | 887 | 0.010 |
Why?
|
| Chromatography, Agarose | 1 | 2000 | 29 | 0.010 |
Why?
|
| Sodium Azide | 1 | 2000 | 24 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2004 | 616 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2016 | 42577 | 0.010 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 2000 | 59 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2005 | 1266 | 0.010 |
Why?
|
| Microsomes | 1 | 2000 | 252 | 0.010 |
Why?
|
| Bleeding Time | 1 | 1999 | 83 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 2062 | 0.010 |
Why?
|
| Registries | 1 | 2016 | 8352 | 0.010 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 1999 | 78 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2012 | 3831 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 2014 | 3229 | 0.010 |
Why?
|
| Molecular Probe Techniques | 1 | 1999 | 111 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 2004 | 1253 | 0.010 |
Why?
|
| Protein Transport | 1 | 2005 | 1944 | 0.010 |
Why?
|
| Thrombospondins | 1 | 1999 | 196 | 0.010 |
Why?
|
| Mesentery | 1 | 1999 | 201 | 0.010 |
Why?
|
| Arterioles | 1 | 1999 | 252 | 0.010 |
Why?
|
| Amino Acids | 1 | 2005 | 1711 | 0.010 |
Why?
|
| RNA Interference | 1 | 2007 | 2829 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2001 | 699 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 2000 | 606 | 0.010 |
Why?
|
| Saphenous Vein | 1 | 2001 | 519 | 0.010 |
Why?
|
| History, 19th Century | 1 | 2001 | 714 | 0.010 |
Why?
|
| Exons | 1 | 2004 | 2392 | 0.010 |
Why?
|
| Genistein | 1 | 1998 | 87 | 0.010 |
Why?
|
| Animal Experimentation | 1 | 1998 | 46 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 15912 | 0.010 |
Why?
|
| Ethics | 1 | 1998 | 93 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1998 | 411 | 0.010 |
Why?
|
| Glycoconjugates | 1 | 1998 | 88 | 0.010 |
Why?
|
| Point Mutation | 1 | 2003 | 1592 | 0.010 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2001 | 452 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2003 | 1531 | 0.010 |
Why?
|
| Intercellular Junctions | 1 | 1998 | 198 | 0.010 |
Why?
|
| Social Control, Formal | 1 | 1998 | 107 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 2952 | 0.010 |
Why?
|
| Receptors, Thrombin | 1 | 1997 | 130 | 0.010 |
Why?
|
| Haplorhini | 1 | 1998 | 520 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 1998 | 458 | 0.010 |
Why?
|
| Fibrin | 1 | 1999 | 514 | 0.010 |
Why?
|
| Phylogeny | 1 | 2004 | 2840 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1998 | 478 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2009 | 3833 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2006 | 1940 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 2001 | 785 | 0.010 |
Why?
|
| Megakaryocytes | 1 | 1999 | 557 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 8928 | 0.010 |
Why?
|
| Directed Molecular Evolution | 1 | 1996 | 167 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 12808 | 0.010 |
Why?
|
| Solubility | 1 | 1996 | 1078 | 0.010 |
Why?
|
| Brain Ischemia | 1 | 2008 | 3001 | 0.010 |
Why?
|
| Complement C3 | 1 | 1996 | 434 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 1998 | 1337 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 36459 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 4780 | 0.010 |
Why?
|
| Advisory Committees | 1 | 1998 | 797 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2007 | 5618 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2013 | 26387 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2003 | 5388 | 0.010 |
Why?
|
| Uncertainty | 1 | 1998 | 765 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2001 | 2764 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 1998 | 1394 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2001 | 6306 | 0.010 |
Why?
|
| Actins | 1 | 1998 | 2061 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 20710 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 1998 | 1673 | 0.010 |
Why?
|
| HIV Infections | 1 | 2015 | 17532 | 0.000 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2005 | 5690 | 0.000 |
Why?
|
| Age Factors | 1 | 2005 | 18397 | 0.000 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 1998 | 1456 | 0.000 |
Why?
|
| Environmental Exposure | 1 | 2001 | 4544 | 0.000 |
Why?
|